CL
UTHR icon

Choreo LLC’s United Therapeutics UTHR Stock Holding History

Choreo LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Sell
622
-140
-18% -$78.8K ﹤0.01% 1242
2026
Q1 		$452K Sell
762
-185
-20% -$92.1K 0.01% 998
2025
Q4 		$470K Buy
947
+20
+2% +$9.31K 0.01% 946
2025
Q3 		$388K Buy
927
+163
+21% +$54.8K 0.01% 1065
2025
Q2 		$220K Buy
+764
New +$228K ﹤0.01% 1352
2025
Q1 		– Sell
-1,132
Closed -$404K – 1603
2024
Q4 		$404K Sell
1,132
-290
-20% -$107K 0.01% 1020
2024
Q3 		$509K Buy
1,422
+368
+35% +$124K 0.01% 895
2024
Q2 		$336K Buy
+1,054
New +$279K 0.01% 1033

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Choreo LLC's UTHR Position: Q2 2026 in Review

Choreo LLC reduced its United Therapeutics (UTHR) stake by 18% in Q2 2026, selling an estimated $78.8K and leaving 622 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Choreo LLC first reported a position in UTHR in Q2 2024 and has held it in 8 quarters since. The position peaked at $509K in Q3 2024. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Choreo LLC held 622 shares of United Therapeutics worth $337K as of Q2 2026.
  • Choreo LLC sold 140 United Therapeutics shares in Q2 2026, an estimated $78.8K.
  • United Therapeutics made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1242 holding.
  • Choreo LLC first reported a position in United Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's United Therapeutics position peaked at $509K in Q3 2024.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.